Page 148 - 南京医科大学学报自然科学版
P. 148
第43卷第4期
·586 · 南 京 医 科 大 学 学 报 2023年4月
volved apoptosis and inflammatory pathways[J]. J Neuro⁃
5 总结与展望
surg,2018,130(3):977-988
越来越多的临床对照研究表明,在缺血性脑卒 [7] FAN Y,DING S,SUN Y,et al. miR⁃377 regulates inflam⁃
中患者的血清、血浆或全血中可以检测到miRNA表 mation and angiogenesis in rats after cerebral ischemic
达的改变。许多 miRNA 与缺血性脑卒中的一些预 injury[J]. J Cell Biochem,2018,119(1):327-337
[8] LI W Y,ZHU Q B,XU X Y,et al. miR⁃27a⁃3p suppresses
后结局相关,如脑梗死体积、脑水肿、卒中严重程
cerebral ischemia⁃reperfusion injury by targeting FOXO1
度。此外,研究证实,在缺血性脑卒中动物模型中,
[J]. Aging,2021,13(8):11727-11737
miRNA模拟物和抑制剂可以穿透血脑屏障,保护大
[9] JONGCHAN K,YAO F,XIAO Z N,et al. microRNAs and
脑免受缺血性损伤。因此,未来miRNA可能成为缺 metastasis:small RNAs play big roles[J]. Cancer Metas⁃
血性脑卒中患者诊断和预后的非侵入性生物标志 tasis Rev,2018,37(1):5-15
物,有望作为治疗的新靶点。 [10] LEWIS B P,BURGE C B,BARTEL D P. Conserved seed
值得注意的是,在卒中治疗中有效使用miRNA pairing,often flanked by adenosines,indicates that thou⁃
仍有一些问题亟待突破。目前,对卒中miRNA的研 sands of human genes are microRNA targets[J]. Cell,
究主要集中在单个miRNA与其靶基因的关系上,对 2005,120(1):15-20
miRNA的共调控网络仍研究甚少,miRNA能否在不 [11] MARANGON D,RAFFAELE S,FUMAGALLI M,et al.
影响其他脏器功能的情况下治疗缺血性脑卒中,这 microRNAs change the games in central nervous system
pharmacology[J]. Biochem Pharmacol,2019,168:162-
仍需要大量的实验验证。协助 miRNA 通过血脑屏
172
障并将其运送到受影响组织的药物是另一个主要
[12] SALIMINEJAD K,KHORRAM KHORSHID H R,SOLEY⁃
挑战。相信随着这些问题的解决,以miRNA为核心
MANI FARD S,et al. An overview of microRNAs:biolo⁃
的核酸靶向治疗可以为缺血性脑卒中患者带来新 gy,functions,therapeutics,and analysis methods[J]. J
的希望。 Cell Physiol,2019,234(5):5451-5465
[参考文献] [13] KROL J,LOEDIGE I,FILIPOWICZ W. The widespread
regulation of microRNA biogenesis,function and decay
[1] CURTIS B,GLANCE L G,DERDEYN C P,et al. Periop⁃
[J]. Nat Rev Genet,2010,11(9):597-610
erative neurological evaluation and management to lower
[14] MEDLEY J C,PANZADE G,ZINOVYEVA A Y. microR⁃
the risk of acute stroke in patients undergoing noncardiac,
NA strand selection:unwinding the rules[J]. Wiley Inter⁃
nonneurological surgery:a scientific statement from the
discip Rev RNA,2021,12(3):1627
American heart association/American stroke association
[15] JUNGERS C F,DJURANOVIC S. Modulation of miRISC⁃
[J]. Circulation,2021,143(19):e923-e946
mediated gene silencing in eukaryotes[J]. Front Mol
[2] VLISIDES P E,MOORE L E. Stroke in surgical patients
Biosci,2022,9:832916
[J]. Anesthesiology,2021,134(3):480-492
[16] LYTLE J R,YARIO T A,STEITZ J A.Target mRNAs are
[3] OSANAI T,HOUKIN K,UCHIYAMA S,et al. Treatment
repressed as efficiently by microRNA⁃binding sites in the
evaluation of acute stroke for using in regenerative cell el⁃
5’UTR as in the 3’UTR[J]. PNAS,2007,104(23):
ements(TREASURE)trial:rationale and design[J]. Int J
9667-9672
Stroke,2018,13(4):444-448
[17] SHONA P,BEGOÑA S L,PAUL D,et al. Circulating miR
[4] RANA R,JIMENEZ⁃MATEOS E M,SEBASTIAN B,et al.
⁃330⁃3p in late pregnancy is associated with pregnancy
Cerebrospinal fluid microRNAs are potential biomarkers outcomes among lean women with GDM[J]. Sci Rep,
of temporal lobe epilepsy and status epilepticus[J]. Sci 2020,10(1):908
Rep,2017,7(1):3328
[18] PORDZIK J,PISARZ K,DE ROSA S,et al. The poten⁃
[5] WU Y K,YAO J,FENG K. miR⁃124⁃5p/NOX2 axis mod⁃ tial role of platelet ⁃ related microRNAs in the develop⁃
ulates the ROS production and the inflammatory microen⁃ ment of cardiovascular events in high⁃risk populations,in⁃
vironment to protect against the cerebral I/R injury[J]. cluding diabetic patients:a review[J]. Front Endocrinol
Neurochem Res,2020,45(2):404-417 (Lausanne),2018,9:74
[6] TIAN Y S,ZHONG D,LIU Q Q,et al. Upregulation of [19] DE ROSA R,DE ROSA S,LEISTNER D,et al. Trans⁃
miR⁃216a exerts neuroprotective effects against ischemic coronary concentration gradient of microRNA ⁃ 133a and
injury through negatively regulating JAK2/STAT3 ⁃ in⁃ outcome in patients with coronary artery disease[J]. Am